A randomized, double-blind, double-dummy, placebo-controlled, 4x4 factorial design trial to evaluate telmisartan 20, 40 and 80 mg tablets in combination with amlodipine 2.5, 5 and 10 mg capsules after eight weeks of treatment in patients with stage I or II hypertension, with an ABPM sub-study.

Trial Profile

A randomized, double-blind, double-dummy, placebo-controlled, 4x4 factorial design trial to evaluate telmisartan 20, 40 and 80 mg tablets in combination with amlodipine 2.5, 5 and 10 mg capsules after eight weeks of treatment in patients with stage I or II hypertension, with an ABPM sub-study.

Completed
Phase of Trial: Phase III

Latest Information Update: 08 May 2014

At a glance

  • Drugs Amlodipine (Primary) ; Telmisartan (Primary)
  • Indications Essential hypertension
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 01 Aug 2010 Results have been published in Blood Pressure Monitoring.
    • 15 Jun 2009 Results were presented at the 19th Scientific Meeting of the European Society of Hypertension, according to a Boehringer-Ingelheim media release.
    • 06 May 2009 Results presented at ASH 2009.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top